Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Acta Neuropathologica2018Vol. 136(1), pp. 153–166
Citations Over TimeTop 1% of 2018 papers
Mitsuaki Shirahata, Takahiro Ono, Damian Stichel, Daniel Schrimpf, David Reuß, Felix Sahm, Christian Koelsche, Annika K. Wefers, Annekathrin Reinhardt, Kristin Huang, Philipp Sievers, Hiroaki Shimizu, Hiroshi Nanjo, Yusuke Kobayashi, Yohei Miyake, Tomonari Suzuki, Jun-ichi Adachi, Kazuhiko Mishima, Atsushi Sasaki, Ryo Nishikawa, Melanie Bewerunge‐Hudler, Marina Ryzhova, O V Absalyamova, Andrey Golanov, Hans‐Peter Sinn, Michael Platten, Christine Jungk, Frank Winkler, Antje Wick, Daniel Hänggi, Andreas Unterberg, Stefan M. Pfister, David Jones, Martin J. van den Bent, Monika E. Hegi, Pim J. French, Brigitta G. Baumert, Roger Stupp, Thierry Gorlia, Michael Weller, David Capper, Andrey Korshunov, Christel Herold‐Mende, Wolfgang Wick, David N. Louis, Andreas von Deimling
Related Papers
- → Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas(2010)840 cited
- → Association between IDH1/2 mutations and brain glioma grade(2018)50 cited
- Role of gemistocytes in astrocytoma progression.(1997)
- → Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma(2012)20 cited
- → MIB-1 labeling index in nonpilocytic astrocytoma of childhood(1998)28 cited